Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950123-09-049470
Filing Date
2009-10-09
Accepted
2009-10-09 11:37:01
Documents
4
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 IDERA PHARMACEUTICALS, INC. b77544e10vkza.htm 10-K/A 70361
2 EX-10.55 AMENDMENT DATED FEBRUARY 12, 2009 TO THE LICENSE AGREEMENT b77544exv10w55.htm EX-10.55 52810
3 EX-31.3 SECTION 302 CERTIFICATION OF CEO b77544exv31w3.htm EX-31.3 3122
4 EX-31.4 SECTION 302 CERTIFICATION OF CFO b77544exv31w4.htm EX-31.4 2872
  Complete submission text file 0000950123-09-049470.txt   130662
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-31918 | Film No.: 091113376
SIC: 2836 Biological Products, (No Diagnostic Substances)